Peptide Synthesis Service Company Profile

Peptron, Inc.

Peptron, Inc., established in 1997, has become a leading life science company providing innovative products and technology to life science researchers, biotech industry, and pharmaceutical companies.

Expertise in peptides and proteins has enabled Peptron to develop sustained release injectable formulation technologies for known peptide and protein drugs.

There are more than 300 peptide drug candidates that are being developed worldwide. Due to recent technologies such as DDS to enhance the stability of the peptides, more peptide drugs are being developed. At Peptron, our drug discovery program focuses on angiogenesis inhibiting peptides, osteoporosis inhibiting peptides, and peptides as ES cell differentiation factors. Peptron is looking forward to partnering with pharmaceutical companies that would develop the discoveries into marketable drug products.

Contact Information

Address: 385-19 Doryong-Dong, Yusong-Gu, Daejeon, 305-340, South Korea
Telephone number: +82-42-862-6451
Fax number: +82-42-862-6456
Web page: www.peptron.com

Go Back

Related categories